Results 71 to 80 of about 10,783,899 (240)

Stimulator of interferon genes agonist augmented antitumor immunity of osimertinib in Egfr‐mutated lung cancer

open access: yesMolecular Oncology, EarlyView.
Combining osimertinib with the STING agonist ADU‐S100 activates innate and adaptive immunity to overcome the non‐inflamed microenvironment of Egfr‐mutant lung cancer. This combination increases NK and CD8+ T‐cell infiltration, associated with activation of the STING‐IRF3 pathway and local immunogenic cell death.
Jun Nishimura   +19 more
wiley   +1 more source

The Effect of Combustion Phase According to the Premixed Ethanol Ratio Based on the Same Total Lower Heating Value on the Formation and Oxidation of Exhaust Emissions in a Reactivity-Controlled Compression Ignition Engine

open access: yesFire
A compression ignition engine generates power by using the auto-ignition characteristics of fuel injected into the cylinder. Although it has high fuel efficiency, it discharges a lot of exhaust emissions such as NOX and PM.
Se-Hun Min, Hyun-Kyu Suh
doaj   +1 more source

MITF maintains genome stability in nonmelanocyte lineages

open access: yesMolecular Oncology, EarlyView.
MITF is essential for melanocyte survival and acts as an oncogene in 10%–20% of melanomas. We show that MITF depletion causes genome instability in nonmelanocytic cells, leading to LATS2‐mediated P53 activation, cell cycle arrest, and apoptosis. This study highlights the role of MITF as a genome maintenance factor beyond the melanocyte lineage. Created
Drifa H. Gudmundsdottir   +13 more
wiley   +1 more source

Methane Number Improvement of Gas from LNG Regasification Unit

open access: yesE3S Web of Conferences, 2018
Methane Number (MN) is one of quality requirement of gas as fuel for gas engine, which indicates fuel capability to avoid knocking in the engine. Higher MN provides better quality of gas for gas engine.
Tjojudo Danianto Hendragiri   +1 more
doaj   +1 more source

A novel quinazolinone insulin receptor inhibitor and its synergy with an EGFR inhibitor in glucose‐driven glioblastoma

open access: yesMolecular Oncology, EarlyView.
The novel styrylquinazolinone‐based molecule W1B effectively suppresses glioblastoma by inhibiting IGF1R and EGFR. In high‐glucose microenvironments driving tumor resistance, W1B acts synergistically with the EGFR inhibitor dacomitinib. This combination safely blocks compensatory survival signaling in zebrafish xenograft models. Showcasing promising in
Patryk Rurka   +9 more
wiley   +1 more source

Comparative analysis of HHV and LHV values of biocoke fuel from palm oil mill solid waste

open access: yesCase Studies in Chemical and Environmental Engineering
This research aims to investigate and compare the energy value of different biocoke and raw palm oil-biomass. Applying pressure and heating simultaneously during biocoke production is a direct method used in this research.
Asri Gani   +7 more
doaj   +1 more source

Oncogenic DMTF1β promotes cancer cell motility by regulating autophagy through ULK1 stabilization

open access: yesMolecular Oncology, EarlyView.
In the current study, we demonstrate that the oncogene DMTF1β regulates ULK1 stability by reducing its proteasomal degradation in cancer cells. This stabilization enables ULK1 to induce autophagy, which in turn facilitates cancer cell migration. Consequently, reduced DMTF1β levels lead to decreased autophagy and impaired cancer cell migration.
Jun Xu   +13 more
wiley   +1 more source

PAK1 activation drives divergent resistance mechanisms to aromatase inhibition and tamoxifen in a luminal: A breast cancer model

open access: yesMolecular Oncology, EarlyView.
Breast cancer remains a major cause of cancer death in women, frequently developing endocrine therapy resistance. This study demonstrates that upregulated p21‐activated kinase 1 (PAK1) activity drives resistance to tamoxifen and long‐term estrogen deprivation in ER+ breast cancer models.
Luisa Schwarzmüller   +10 more
wiley   +1 more source

Inhibition of cyclin‐dependent kinases 12/13 using CT7439 as a treatment for colorectal cancer with CDK12 upregulation

open access: yesMolecular Oncology, EarlyView.
The proposed mechanism of action for the CDK12/13 inhibitor and cyclin K degrader, CT7439. CDK12/13 inhibition interrupts transcription elongation, leading to increased DNA damage that results in cell death. This agent is a potentially novel treatment option for patients with colorectal cancer. Created in BioRender. Cyclin‐dependent kinase (CDK) 12 and
Wylie K. Watlington   +10 more
wiley   +1 more source

Investigation of Co-gasification Characteristics of Wood-coconut Fibers Pellet and Rice Husk Mixtures in a Downdraft Fixed Bed Gasifier

open access: yesInternational Journal of Technology, 2017
Increasing energy demand, in line with the rate of population growth, is always followed by the pace of the waste dump. Where the largest percentage comes from organic waste, it is potentially utilized as raw material of biomass mixture for emission ...
Apri Wiyono   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy